News

Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference

LONDON, Ontario, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative…

2 years ago

VitalHub Announces Multi Year Contract With NHS Mid and South Essex ICB

TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce a…

2 years ago

Altimmune Announces First Dosing of All Subjects in Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight

Twenty-four week interim analysis on approximately 160 subjects planned for Q1 2023GAITHERSBURG, Md., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Altimmune,…

2 years ago

Cytokinetics Announces Call for Proposals for Its Fifth Annual Communications Grant Program

Program to Provide $100,000 in Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular and Neuromuscular Diseases…

2 years ago

Velocity Clinical Research reveals findings from US patient survey on decentralization in clinical research

Velocity Clinical Research: The US Patient Survey 2022, Decentralization in Clinical Research. Dr G. Paul Evans, Chief Executive and President…

2 years ago

Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation

SOUTH ORANGE, NJ, Sept. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology…

2 years ago

KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate (SDX)

SDX administered at single doses of 80 mg and 200 mg was well-tolerated CELEBRATION, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE)…

2 years ago

ReWalk Takes Another Step Toward Medicare Coverage

ReWalk to submit first cases for Medicare coverage through Medicare Administrative Contractors (MACs)Centers for Medicare and Medicaid Services (CMS) affirms…

2 years ago

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future…

2 years ago

OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test

BETHLEHEM, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home…

2 years ago